Table 2.

Reasons for previous dofetilide discontinuation

	Number (%)
Total patients	138 (100 %)
Patients with known discontinuation data	75 (54.3 %)
Average days of dofetilide discontinuation	660 days
Reasons for previous dofetilide discontinuation*
Ineffectiveness	50 (66.7 %)
Successful cardioversion	24 (32.0 %)
Another provider discontinued	13 (17.3 %)
QTc prolongation	10 (13.3 %)
System error/Forgotten by provider	5 (6.7 %)
Financial burden on patient	5 (6.7 %)
Presence of infection	4 (5.3 %)
Pulmonary vein isolation	3 (4.0 %)
Initial loading failed	2 (2.7 %)
Acute kidney injury	2 (2.7 %)
Need for surgery	1 (1.3 %)
Left atrial appendage clot	1 (1.3 %)
Failed absorption	1 (1.3 %)
Bradycardia	1 (1.3 %)
Patient compliance concerns	1 (1.3 %)

^*Patients may have more than one reason for discontinuation.